|
PDCD11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.561700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.093000E-01 |
| Normal-vs-Stage2 |
2.789200E-01 |
| Normal-vs-Stage3 |
1.102830E-01 |
| Normal-vs-Stage4 |
1.348840E-01 |
| Stage1-vs-Stage2 |
3.682200E-01 |
| Stage1-vs-Stage3 |
2.056200E-01 |
| Stage1-vs-Stage4 |
7.199500E-02 |
| Stage2-vs-Stage3 |
6.960800E-01 |
| Stage2-vs-Stage4 |
4.699000E-01 |
| Stage3-vs-Stage4 |
7.046400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.394000E-02 |
| Normal-vs-AfricanAmerican |
2.232400E-01 |
| Normal-vs-Asian |
5.082600E-01 |
| Caucasian-vs-AfricanAmerican |
8.879800E-01 |
| Caucasian-vs-Asian |
7.614800E-01 |
| AfricanAmerican-vs-Asian |
7.490800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.783000E-01 |
| Normal-vs-Female |
7.77510000000703E-05 |
| Male-vs-Female |
5.63479999999839E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.166800E-01 |
| Normal-vs-Extreme_Weight |
7.731000E-01 |
| Normal-vs-Obese |
1.424430E-02 |
| Normal-vs-Extreme_Obese |
7.593800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.139780E-01 |
| Normal_Weight-vs-Obese |
3.573800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.202000E-01 |
| Extreme_Weight-vs-Obese |
4.019500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.974200E-01 |
| Obese-vs-Extreme_Obese |
2.882200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.244680E-03 |
| Normal-vs-Age(41-60Yrs) |
6.655900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.515200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.248000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.221100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.881300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.803550E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.930000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.302110E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.598000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.929970E-01 |
| Normal-VS-Type2 PRCC |
9.875800E-01 |
| Normal-VS-KIRP CIMP |
4.657400E-03 |
| Normal-VS-Unclassified PRCC |
2.291900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.959630E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.175700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.369600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.779600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.047600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.622140E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.091400E-01 |
| Normal-vs-N1 |
8.019300E-03 |
| Normal-vs-N2 |
4.383200E-01 |
| N0-vs-N1 |
4.962200E-03 |
| N0-vs-N2 |
1.498780E-01 |
| N1-vs-N2 |
7.219600E-01 |
|
|
